MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Rheumatoid Arthritis.

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

Have you been diagnosed with Rheumatoid Arthritis? Try to add these 5 medicinal leaves to your daily diet routine to get ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, ...

Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus.

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Moderate alcohol consumption and eating oily fish, fruits, and cereals may reduce the risk for rheumatoid arthritis.

USA: Recent findings published in Arthritis Care and Research suggest that individuals with rheumatoid arthritis (RA) face an ...

Magnesium deficiency may elevate the risks for rheumatoid arthritis (RA) and osteoarthritis (OA), according to study findings ...

Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, ...

Ivarmacitinib, a novel Janus kinase 1 inhibitor, may be considered a potential treatment for patients with moderate to severe ...

Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus.